Loading clinical trials...

Safety and Pharmacokinetic Characteristics of DKF-313 | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT02352311

Safety and Pharmacokinetic Characteristics of DKF-313

This is a randomized, open-label, single-dose, 2-treatment, 2-way, 2-period crossover study to evaluate the safety and the pharmacokinetic characteristics of DKF-313 (dutasteride and tadalafil) in hea...

Lead sponsor: Dongkook Pharmaceutical Co., Ltd.•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function

NCT07269301 · Hepatic Impairment, Healthy

RECRUITINGNA

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

NCT05545306 · Obesity, Normal Physiology, and more

RECRUITINGPhase 1

A Trial to Assess Safety, Tolerability, and Pharmacokinetics of AN01 Inhalation Powder in Healthy Participants

NCT07554365 · Healthy Volunteer, Healthy Participants Study

RECRUITINGNA

Adipose Tissue Blood Flow in Aging Humans

NCT06096532 · Healthy, Aging

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 6, 2021Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment54

Start dateJan 2015

Last updatedJul 6, 2021

Condition

Benign Prostate Hyperplasia Healthy

Locations shown

Chonbuk National University Hospital

Jeonju, Jeollabuk-do

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions